Skip to main content
SNES logo

SNES · SenesTech, Inc. · Documents

Track SNES — free
$0.73 +0.08 (+11.56%) Play latest call Q3 2026 earnings call transcript
Market Cap
$4.46M
Shares
6.82M
Volume · Nov 20 20.18K Avg daily vol (3M) 1.04M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $2.22M up 19.6% 10-K filed Mar 13, 2026 Quarterly report New FY2026 Q3 Revenue $1.1M up 59.0% 10-Q filed Nov 13, 2026 Latest results Q3 revenue hits record $1.097 million, up 59% 8-K filed Nov 10, 2026 Earnings call Q3 2026 earnings call Held Nov 10, 2026
2026
Nov 17
Current report 8-K Events of Nov 16
Adds JoAnna Abrams as Independent Director; Board Grows to Eight

SenesTech appointed JoAnna Abrams to its Board of Directors effective November 16, 2026, as an independent director, increasing the Board to eight members. She also joins the Commercialization Committee.

Director or officer change, or executive pay
3 source passages
On November 16, 2026, our Board of Directors (the “Board”) authorized an increase in the size of the Board to eight members and appointed JoAnna Abrams to serve on the Board as an independent director. SenesTech, Inc. (NASDAQ: SNES), an innovator in responsible rodent population management, today announced the appointment of JoAnna Abrams to its Board of Directors, effective November 16, 2026. Ms. Abrams was also appointed to serve as a member of the Commercialization Committee of the Board. Open the document at this passage
Nov 13
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises as margin improves; financing still needed

SenesTech reported third-quarter 2026 revenue of $1.1 million, up from $690,000, and gross margin of 72.6%, versus 62.8%. Nine-month net loss was $5.9 million; management said additional financing will be needed before profitability.

Revenue $1.1M ▲ 59.0% Net loss $1.96M Diluted EPS -$0.36
Read from the MD&A section
5 source passages
Over the past year, SenesTech has transformed from a research-focused organization into a revenue-driven company with a strategy focused on the commercialization of its proprietary pest management technologies for managing animal pest populations through fertility control. Sales, net of sales discounts and promotions, were $1.1 million for the third quarter of 2026, compared to $690,000 for the third quarter of 2025. Gross profit for the third quarter of 2026 was $796,000, representing a margin of 72.6%, compared to $433,000, or 62.8% margin, in the third quarter of 2025. Since our inception, we have incurred operating losses related to our research and development activities and commercialization efforts, with a net loss of $5.9 million for the nine months ended September 30, 2026, and we expect these losses to continue for the near future. Additional financing will be needed in order to fund our operating losses before achieving our revenue and margin targets and becoming profitable and generating positive cash flows. Open the document at this passage
Nov 10
Earnings call
Revenue Tops $1 million, Subscription Customers Rise 72%

Synestec reported third-quarter revenue of $1.1 million, up 42% sequentially and 59% year-over-year, surpassing $1 million for the first time. Gross profit reached a record $796,000, while combined subscription customers across Amazon and its website increased 72%.

2 source passages
This was a milestone quarter for Synestec. We surpassed $1 million in quarterly revenue for the first time in our history. Revenue reached approximately $1.1 million, growing 42% from the second quarter and 59% from a year ago. Rose Profit reached a record $796,000, and combined subscription customers across Amazon and our website increased 72% in just one quarter. Open the document at this passage
Nov 10
Current report 8-K
Q3 revenue hits record $1.097 million, up 59%

SenesTech reported record Q3 2026 revenue of $1.097 million, up 59% from Q3 2025, and gross profit of $796,000. Net loss was $2.0 million, and cash and cash equivalents ended at $4.0 million.

Financial results
5 source passages
SenesTech, Inc. (NASDAQ: SNES), an innovator in rodent control, today announced financial results for the third quarter ended September 30, 2026. Total revenue increased 42% sequentially to a record $1.097 million in Q3 2026, compared to $770,000 in Q2 2026, and increased 59% compared to $690,000 in Q3 2025. Gross profit increased 40% to a record $796,000 in Q3 2026, compared to $567,000 in Q2 2026, and increased 84% compared to $433,000 in Q3 2025. Net loss for Q3 2026 was $2.0 million, compared to $1.8 million in Q2 2026, and $1.3 million in Q3 2025. Cash and cash equivalents decreased $1.1 million during Q3 2026 to $4.0 million. Open the document at this passage
Oct 22
Current report 8-K Events of Oct 20
Nasdaq Bid Price Notice Received; Record Third Quarter Revenue

SenesTech received a Nasdaq letter on October 20, 2026, saying its bid price closed below $1.00 for 30 consecutive business days. Preliminary third quarter revenue was approximately $1.1 million, the highest in its history.

Delisting notice or listing transfer, Regulation FD disclosure
2 source passages
today announced that, on Oct. 20, 2026, it received a letter from the listing qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the closing bid price of its common stock had been below $1.00 per share for 30 consecutive business days. “Our preliminary third quarter revenue of approximately $1.1 million was the highest in the Company’s history, up 40% from the second quarter and 55% from the third quarter of 2025. Open the document at this passage
Oct 15
Current report 8-K
Financial results

SenesTech reported preliminary third quarter of 2026 revenue of approximately $1.1 million, approximately 40% growth versus second quarter of 2026 and approximately 55% growth versus third quarter of 2025; definitive results are planned for the week of November 9, 2026.

Aug 6
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $770K ▲ 23.2% Net loss $1.83M Diluted EPS -$0.35
May 13
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $493K ▲ 1.6% Net loss $2.06M Diluted EPS -$0.39
Apr 29
Proxy statement DEF 14A Meeting Jun 9, 2026
Proxy statement AI summary on its way
Mar 13
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $2.22M ▲ 19.6% Net loss $6.38M Diluted EPS -$1.95
2025
Showing 1–50 of 194 documents
Key facts CIK 1680378 CUSIP 81720R604 13F (30d) 26 filings 23 filers Visit website Investor relations